(MedPage Today) — PHOENIX — Cardiovascular inflammation was highly prevalent among U.S. heart failure (HF) patients, a registry study found, illustrating the unmet need for good inflammation-targeting pharmacotherapy.
In a subanalysis of POSEIDON…
Source link
Rampant Inflammation in Heart Failure: Can Anything Be Done About It?
